Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 2-year Outcomes

被引：0
|
作者：
Le Hong, Thomas Hai [1 ]
Broadhead, Geoffrey [1 ]
Joachim, Nichole [1 ]
Wong, Lily [1 ]
Zhu, Meidong [1 ]
Chang, Andrew Alexander [1 ]
机构：
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4593
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [42] PHARMACOKINETIC STUDY OF INTRAVITREAL AFLIBERCEPT IN HUMANS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Do, Diana V.
    Rhoades, William
    Nguyen, Quan Dong
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (04): : 643 - 647
  • [43] Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration and Pigment Epithelial Detachment
    Cidad Betegon, Maria del Pino
    Felix, Armada
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [44] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Rachel Hui Fen Lim
    Bhaskar Gupta
    Peter Simcock
    [J]. International Journal of Ophthalmology, 2017, (03) : 423 - 426
  • [45] Three-year Outcomes of Treat and Extend Aflibercept Treatment for Neovascular Age-related Macular Degeneration
    Kataoka, Keiko
    Asai, Keiko
    Tsunekawa, Yuma
    Ito, Yasuki
    Terasaki, Hiroko
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [46] TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Barthelmes, Daniel
    Vuong Nguyen
    Daien, Vincent
    Campain, Anna
    Walton, Richard
    Guymer, Robyn
    Morlet, Nigel
    Hunyor, Alex P.
    Essex, Rohan W.
    Arnold, Jennifer J.
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (01): : 20 - 28
  • [47] Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW
    Michel Weber
    Marcel Dominguez
    Florence Coscas
    Céline Faure
    Stéphanie Baillif
    Laurent Kodjikian
    Salomon-Yves Cohen
    [J]. BMC Ophthalmology, 20
  • [48] Current Strategies for the Management of Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Freund K.B.
    Mrejen S.
    Gallego-Pinazo R.
    [J]. Current Ophthalmology Reports, 2014, 2 (1) : 6 - 13
  • [49] Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration
    Venzara, Frank
    Mason, John
    Glover, Jay
    McGwin, Gerald
    Huisingh, Carrie
    Friedman, Duncan
    Feist, Richard
    Thomley, Martin
    Albert, Michael
    Price, Natalie
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [50] One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration
    Arcinue, Cheryl A.
    Ma, Feiyan
    Barteselli, Giulio
    Sharpsten, Lucie
    Gomez, Maria Laura
    Freeman, William R.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (03) : 426 - 436
12345